Neuroimaging

The Division of Neuroscience, NIA sponsored this informational meeting to convene experts on neuroimaging in Alzheimer’s disease and mild cognitive impairment (MCI). Attendees represented academia, pharmaceutical companies, imaging companies, NIH program staff, the NIH Office of the Director, the Food and Drug Association, the Alzheimer’s Association, and the Institute for the Study of Aging. Approximately 38 people attended.

The Division of Neuroscience, NIA developed an Alzheimer’s Disease Neuroimaging Initiative, which is a partnership among NIA/NIH, academic investigators, the pharmaceutical industry, and the imaging equipment industry. Other participants included the Alzheimer’s Association and Institute for the Study of Aging. The Alzheimer's Disease Neuroimaging Initiative Advisory Meeting included representatives from each of these entities.